These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27328801)

  • 1. Meta-analysis and systematic review of procalcitonin-guided treatment in acute exacerbation of chronic obstructive pulmonary disease.
    Lin C; Pang Q
    Clin Respir J; 2018 Jan; 12(1):10-15. PubMed ID: 27328801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis.
    Li Z; Yuan X; Yu L; Wang B; Gao F; Ma J
    Medicine (Baltimore); 2019 Aug; 98(32):e16775. PubMed ID: 31393400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
    Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
    Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial.
    Huang L; Wang J; Gu X; Sheng W; Wang Y; Cao B
    BMJ Open; 2021 Aug; 11(8):e049515. PubMed ID: 34353802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin-guided antibiotic therapy in AECOPD patients: Overview of systematic reviews.
    Di J; Li X; Xie Y; Yang S; Yu X
    Clin Respir J; 2021 Jun; 15(6):579-594. PubMed ID: 33683808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials].
    Zhang L; Huang J; Xu T; Lin Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Apr; 35(4):275-82. PubMed ID: 22781200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis.
    Soni NJ; Samson DJ; Galaydick JL; Vats V; Huang ES; Aronson N; Pitrak DL
    J Hosp Med; 2013 Sep; 8(9):530-40. PubMed ID: 23955852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
    Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
    Wang J; Cao B
    Curr Opin Pulm Med; 2019 Mar; 25(2):158-164. PubMed ID: 30550505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.
    Zhang HL; Tan M; Qiu AM; Tao Z; Wang CH
    BMC Pulm Med; 2017 Dec; 17(1):196. PubMed ID: 29233130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
    Albrich WC; Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Bachli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Gaillat J; Schuetz P; Regez K; Bossart R; Schild U; Mueller B;
    Arch Intern Med; 2012 May; 172(9):715-22. PubMed ID: 22782201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.
    Tokman S; Schuetz P; Bent S
    Expert Rev Anti Infect Ther; 2011 Jun; 9(6):727-35. PubMed ID: 21692680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Ulrich RJ; McClung D; Wang BR; Winters S; Flanders SA; Rao K
    Infect Dis (Auckl); 2019; 12():1178633719852626. PubMed ID: 31223234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.